Renal resistive index for renovascular hypertension: In the quest of the Holy Grail

Renal resistive index for renovascular hypertension: In the quest of the Holy Grail Arterial hypertension represents a major public health problem that affects more than 1 billion individuals worldwide, and the number significantly increased with the new more aggressive definition (systolic blood pressure [BP] >130 mm Hg) by the American Heart Association. A specific cause of BP elevation cannot be identified in the majority of patients (essential hypertension), while secondary causes can be identified in 5% to 15%, forming the group of secondary hypertension. Until now, more than 50 causes of secondary hypertension have been reported with various incidence. The combination of the increased prevalence of arterial hypertension in the general population and the subsequent huge absolute number of patients along with the large number of secondary causes from a variety of systems and organs renders ideal screening tests as the “Holy Grail” of appropriate management of patients with arterial hypertension.Renovascular hypertension has been traditionally considered the most common cause of secondary hypertension. The advent of renal artery angioplasty for the successful opening of the occluded renal artery made renovascular hypertension a popular research topic during the last 2 to 3 decades of the 20th century. However, two factors have dampened scientific enthusiasm: (1) the failure of renal artery angioplasty to prove its superiority over http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Hypertension Wiley

Renal resistive index for renovascular hypertension: In the quest of the Holy Grail

Loading next page...
 
/lp/wiley/renal-resistive-index-for-renovascular-hypertension-in-the-quest-of-ouPxr1H4vM
Publisher
Wiley
Copyright
Copyright © 2018 Wiley Periodicals, Inc.
ISSN
1524-6175
eISSN
1751-7176
D.O.I.
10.1111/jch.13221
Publisher site
See Article on Publisher Site

Abstract

Arterial hypertension represents a major public health problem that affects more than 1 billion individuals worldwide, and the number significantly increased with the new more aggressive definition (systolic blood pressure [BP] >130 mm Hg) by the American Heart Association. A specific cause of BP elevation cannot be identified in the majority of patients (essential hypertension), while secondary causes can be identified in 5% to 15%, forming the group of secondary hypertension. Until now, more than 50 causes of secondary hypertension have been reported with various incidence. The combination of the increased prevalence of arterial hypertension in the general population and the subsequent huge absolute number of patients along with the large number of secondary causes from a variety of systems and organs renders ideal screening tests as the “Holy Grail” of appropriate management of patients with arterial hypertension.Renovascular hypertension has been traditionally considered the most common cause of secondary hypertension. The advent of renal artery angioplasty for the successful opening of the occluded renal artery made renovascular hypertension a popular research topic during the last 2 to 3 decades of the 20th century. However, two factors have dampened scientific enthusiasm: (1) the failure of renal artery angioplasty to prove its superiority over

Journal

Journal of Clinical HypertensionWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off